# A Open-label, Single-dose Study to Investigate The Pharmacokinetics Between a GL2907 XL and Oxycontin CR Tab. 10mg in Healthy Male Volunteers

> **NCT01568450** · PHASE1 · COMPLETED · sponsor: **GL Pharm Tech Corporation** · enrollment: 24 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Oxycodone
- **DRUG:** Oxycodone
- **DRUG:** Oxycodone

## Key facts

- **NCT ID:** NCT01568450
- **Lead sponsor:** GL Pharm Tech Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-03
- **Primary completion:** 2012-04
- **Final completion:** 2012-04
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2013-01-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01568450

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01568450, "A Open-label, Single-dose Study to Investigate The Pharmacokinetics Between a GL2907 XL and Oxycontin CR Tab. 10mg in Healthy Male Volunteers". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01568450. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*